[Features of developing resistance during combined use of antineoplastic agents, causing multiple drug resistance].
Goncharova
S A
SA
Demidova
N S
NS
Shiriaeva
O A
OA
Konovalova
N P
NP
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D003078:Colchicine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D004351:Drug Resistance / Q000235:genetics*; D007941:Leukemia P388 / Q000188:drug therapy / Q000235:genetics*; D051379:Mice; D010641:Phenotype; D014750:Vincristine / Q000494:pharmacology
D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin; D003078:Colchicine; D003630:Daunorubicin
Osobennosti razvitiia rezistentnosti pri kominirovannom primenenii protivoopukholevykh preparatov, vyzyvaiushchikh mnozhestvennuiu lekarstvennuiu ustoĭchivost'.